Literature DB >> 26947330

Metformin for cancer prevention: a reason for optimism.

Andrew T Chan1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26947330     DOI: 10.1016/S1470-2045(16)00006-1

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN: 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  13 in total

1.  A Phase IIa Trial of Metformin for Colorectal Cancer Risk Reduction among Individuals with History of Colorectal Adenomas and Elevated Body Mass Index.

Authors:  Jason A Zell; Christine E McLaren; Timothy R Morgan; Michael J Lawson; Sherif Rezk; C Gregory Albers; Wen-Pin Chen; Joseph C Carmichael; Jinah Chung; Ellen Richmond; L M Rodriguez; Eva Szabo; Leslie G Ford; Michael N Pollak; Frank L Meyskens
Journal:  Cancer Prev Res (Phila)       Date:  2019-12-09

2.  Colorectal Cancer Survivors' Receptivity toward Genomic Testing and Targeted Use of Non-Steroidal Anti-Inflammatory Drugs to Prevent Cancer Recurrence.

Authors:  Denalee M O'Malley; Cindy K Blair; Alissa Greenbaum; Charles L Wiggins; Ashwani Rajput; Vi K Chiu; Anita Y Kinney
Journal:  J Community Genet       Date:  2022-01-08

Review 3.  Plk1 Inhibitors in Cancer Therapy: From Laboratory to Clinics.

Authors:  Rosie Elizabeth Ann Gutteridge; Mary Ann Ndiaye; Xiaoqi Liu; Nihal Ahmad
Journal:  Mol Cancer Ther       Date:  2016-06-21       Impact factor: 6.261

Review 4.  Insulin-Sensitizers, Polycystic Ovary Syndrome and Gynaecological Cancer Risk.

Authors:  Rosa Lauretta; Giulia Lanzolla; Patrizia Vici; Luciano Mariani; Costanzo Moretti; Marialuisa Appetecchia
Journal:  Int J Endocrinol       Date:  2016-09-20       Impact factor: 3.257

Review 5.  Metformin and Colorectal Cancer.

Authors:  Takuma Higurashi; Atsushi Nakajima
Journal:  Front Endocrinol (Lausanne)       Date:  2018-10-23       Impact factor: 5.555

6.  Metformin reduces prostate cancer risk among men with benign prostatic hyperplasia: A nationwide population-based cohort study.

Authors:  Yu-Jui Kuo; Fung-Chang Sung; Po-Fan Hsieh; Hui-Ping Chang; Kun-Ling Wu; Hsi-Chin Wu
Journal:  Cancer Med       Date:  2019-04-09       Impact factor: 4.452

7.  HyperFoods: Machine intelligent mapping of cancer-beating molecules in foods.

Authors:  Kirill Veselkov; Guadalupe Gonzalez; Shahad Aljifri; Dieter Galea; Reza Mirnezami; Jozef Youssef; Michael Bronstein; Ivan Laponogov
Journal:  Sci Rep       Date:  2019-07-03       Impact factor: 4.379

Review 8.  Chemoprevention of colorectal cancer: Past, present, and future.

Authors:  Shotaro Umezawa; Takuma Higurashi; Yasuhiko Komiya; Jun Arimoto; Nobuyuki Horita; Takeshi Kaneko; Motoki Iwasaki; Hitoshi Nakagama; Atsushi Nakajima
Journal:  Cancer Sci       Date:  2019-09-17       Impact factor: 6.716

9.  Molecular features that predict the response to antimetabolite chemotherapies.

Authors:  Mahya Mehrmohamadi; Seong Ho Jeong; Jason W Locasale
Journal:  Cancer Metab       Date:  2017-10-03

10.  Metformin reverses the drug resistance of cisplatin in irradiated CNE-1 human nasopharyngeal carcinoma cells through PECAM-1 mediated MRPs down-regulation.

Authors:  Yingming Sun; Xiaochuan Chen; Yajuan Zhou; Sufang Qiu; Yongyang Wu; Min Xie; Guofang Zhu; Shanshan Liang; Heming Li; Dong Zhou; Zaishuang Ju; Fuguang Wang; Fang Han; Zhe Wang; Ruoyu Wang
Journal:  Int J Med Sci       Date:  2020-09-01       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.